Tilifodiolide is primarily used in the pharmaceutical industry due to its potential bioactive properties. It has shown promise in preclinical studies for its anti-inflammatory and neuroprotective effects, making it a candidate for research in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Its ability to modulate cellular signaling pathways involved in oxidative stress and apoptosis supports its investigation as a therapeutic agent. Additionally, tilifodiolide has been explored for its antimicrobial activity, particularly against drug-resistant bacterial strains, offering potential in developing new antibiotics. Ongoing research focuses on optimizing its delivery and bioavailability for clinical applications.